ICU Medical, Inc. is engaged in the development, manufacture and sale of medical devices used in vascular therapy, oncology and critical care applications. The Company’s products prevent bloodstream infections and protect healthcare workers and patients from exposure to infectious diseases or hazardous drugs and monitor the hemodynamic status of critical care patients. The Company’s product line includes custom intravenous (I.V.) systems, closed delivery systems for hazardous drugs, needleless I.V. connectors, catheters and cardiac monitoring systems. The Company is a manufacturer of custom infusion sets. During the year ended December 31, 2010, the Company’s custom infusion set sales accounted for approximately 27% of its revenue. During 2010, its developed products used in oncology therapy, dialysis and diabetes accounted for 9% of its revenue. These products include the TEGO for use in dialyses and the Orbit 90 diabetes set.